1. A composition for oral administration to a subject, the composition comprising: a) a targeting moiety comprising an anti-ICAM antibody; and b) an agent, wherein the targeting moiety recognizes and binds to ICAM-1 on a gastrointestinal epithelial cell and the composition is transported across the gastrointestinal epithelium.